为了改善患者的获取,VIVUS在北欧国家和波兰降低了其药物QSIVA®的价格. VIVUS has lowered the price of its drug QSIVA® in the Nordic countries and Poland to improve patient access.

维乌斯证实其药物QSIVA®的降价现已在北欧国家和波兰生效,使该药物更容易获得. VIVUS has confirmed that the price reduction for its drug QSIVA® is now in effect across the Nordic countries and Poland, making the medication more accessible in those regions. 这一变化是公司早些时候宣布的, 标志着扩大患者负担能力的一个关键步骤. The change follows the company's earlier announcement and marks a key step in expanding affordability for patients. 没有提供有关定价或影响的进一步细节. No further details on pricing or impact were provided.